Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 1 - 20 of 284
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Oct 2016, 7:18 am by Evidence ProfBlogger
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the United States Supreme Court replaced the old Frye test for determining the admissibility of expert evidence with the new Daubert, pursuant to which judges serve as gatekeepers and... [read post]
28 Dec 2018, 2:22 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), appealed a Ninth Circuit ruling that the Frye rule survived, and was incorporated into, the enactment of a statutory evidentiary rule, Rule 702. [read post]
2 Mar 2017, 8:22 pm by Adam Music
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), set the standard for admissibility of scientific expert testimony under the Federal Rules of Evidence (FRE). [read post]
8 Jul 2011, 8:52 am by Expert Witness Guru
MERRELL DOW PHARMACEUTICALS, INC., laying down the foundation of admissibility of scientific expert testimony. [read post]
17 Nov 2018, 12:10 pm by Schachtman
To be sure, judges have often poorly expressed their reasoning for deciding scientific evidentiary issues, and perhaps poor communication or laziness by judges was responsible for Rothman’s interest in joining the Daubert fray. [read post]
25 Jun 2019, 5:00 am by Dani Alexis Ryskamp
Merrell Dow Pharmaceuticals when it comes to qualifying expert witnesses. [read post]
20 Aug 2014, 7:12 pm by Maureen Johnston
AstenJohnson, Inc. 13-1252 Issue: Whether, in a federal jury case, a district judge’s procedural failure to make detailed findings under Daubert v. [read post]
1 Dec 2010, 11:02 am by Scott Koller
Merrell Dow Pharmaceuticals set the standard  regarding the admissibility of expert witness testimony in federal court. [read post]
18 Feb 2009, 12:01 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 589 (1993) Can the Daubert requirement be fulfilled during the trial? [read post]
25 Oct 2011, 9:05 am by Robert C. Weill
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 595 (1993), that “[e]xpert evidence can be both powerful and quite misleading because of the difficulty in evaluating it. [read post]
22 Oct 2015, 1:29 pm by Jo Ann Hoffman & Associates, P.A.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), you must object to an expert, such as a doctor, when his testimony does not comply with Fla. [read post]
14 Sep 2017, 6:00 am by Dani Alexis Ryskamp
Merrell Dow Pharmaceuticals, Inc., a Supreme Court case that changed the landscape of expert witness testimony and case preparation when it was decided in 1993. [read post]
14 Sep 2017, 6:00 am by Dani Alexis Ryskamp
Merrell Dow Pharmaceuticals, Inc., a Supreme Court case that changed the landscape of expert witness testimony and case preparation when it was decided in 1993. [read post]
2 Jul 2013, 6:17 am by Sean Wajert
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]